Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patriot National Bancorp | NASDAQ | Finanziario | Servizi bancari | 241,82 Mln USD | -0,2x | 0 | 3,28 USD | 73,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Hertz Global Holdings | NASDAQ | Industriali | Servizio di trasporto passeggeri | 2,53 Mrd USD | -0,4x | 0 | 8,24 USD | 44,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -63,6% Ribasso | Fai l’upgrade a Pro+ | |
Uniqure NV | NASDAQ | Salute | Ricerca medica e biotecnologica | 703 Mln USD | -2,5x | -0,08 | 13 USD | 38,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Fatpipe | NASDAQ | Tecnologia | Software e servizi IT | 170,57 Mln USD | 12,43 USD | 37,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Zhengye Biotechnology Holding | NASDAQ | Salute | Prodotti farmaceutici | 476,76 Mln USD | -1,29 | 10,06 USD | 32% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Stem | NYSE | Energia | Energia rinnovabile | 61,36 Mln USD | -0,1x | 0 | 0,37 USD | 26,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,3% Rialzo | Fai l’upgrade a Pro+ | |
Agenus | NASDAQ | Salute | Ricerca medica e biotecnologica | 52,64 Mln USD | -0,2x | -0,01 | 2,08 USD | 26,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
ALT5 Sigma | NASDAQ | Tecnologia | Tecnologia finanziaria (fintech) e infrastrutture | 79,40 Mln USD | -7,6x | -0,13 | 5,15 USD | 21,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Kodiak Sciences | NASDAQ | Salute | Ricerca medica e biotecnologica | 149,46 Mln USD | -0,7x | -0,02 | 2,84 USD | 20,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 40,8% Rialzo | Fai l’upgrade a Pro+ | |
Tiziana Life Sciences | NASDAQ | Salute | Ricerca medica e biotecnologica | 116,72 Mln USD | -7,6x | -0,22 | 1,07 USD | 20,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |